Determining the Relationship between Bangkokian’s Willingness to Receive COVID-19 Vaccination and their Knowledge, Attitude, and Practice (KAP) towards the Contagion

In the age of COVID-19 where a lethal contagion is ubiquitous across the globe, vaccination is of supreme significance. Vaccines provide immunity to individuals, rendering them less susceptible to SARS-CoV-2 infection or their symptoms less severe should they ultimately become infected. Vaccinating an adequate proportion of the population can majorly contribute to the achievement of herd immunity, consequently depressing the spread of the Coronavirus and ushering humanity towards eventual subjugation of the ongoing pandemic. Unfortunately, there are obstacles preventing such a roseate prospect from realization, one of which is vaccine hesitancy. Interestingly, past research in various regions around the world has associated this factor, partially, with the public’s knowledge and attitude concerning COVID-19, which could be measured by the Knowledge, Attitude and Practice (KAP) towards COVID-19 scale. Such an association plausibly intimates that a public campaign shedding light on accurate information about the contagion might be of help in augmenting people’s willingness to receive vaccination against the SARS-CoV-2 virus. Because circumstances inevitably varied from place to place, population to population, this study was undertaken to explore whether any similar association existed in Bangkok, Thailand, where the pandemic has been growing progressively worse, with the initial hypothesis that it did. However, results revealed that while there was indeed a statistically significant correlation between Bangkokians’ willingness to receive COVID-19 vaccines and their KAP towards the contagion, the correlation was weak (r = 0.30). This evinces the need for a more thorough and farther-reaching study and, until such a study has been meaningfully concluded, the appropriacy of apposite agencies concentrating elsewhere in their efforts to vanquish vaccine hesitancy and accomplish herd immunity against COVID-19.